Best Peptides for Cognitive Enhancement: Evidence-Ranked Guide

Cognitive enhancement peptides represent a frontier area. The best-studied compounds, Cerebrolysin, Semax, and Selank, are approved in Russia, Europe, or Asia but remain research-only in the US. This category also includes nootropic peptides like Noopept, frontier compounds like Dihexa, and neurotrophic factor fragments that are still purely experimental. This reference profiles 23 peptides and compounds studied for cognitive enhancement, neuroprotection, and brain function. Each is ranked by scientific evidence strength, with international approval status clearly marked.

How to Read Evidence Ratings

★★★★★

Strong Clinical Evidence

Multiple high-quality human clinical studies consistently support the effect.

★★★★☆

Good Human Evidence

Meaningful human data, but may be limited by study size or design.

★★★☆☆

Preliminary Human Evidence

Some human research exists, but early, limited, or mixed.

★★☆☆☆

Primarily Preclinical

Evidence from animal or lab studies. Limited or no human data.

★☆☆☆☆

Mechanistic Only

Plausible mechanism, but little direct evidence for the claimed outcome.

★★★★☆ / ★★☆☆☆

Split Rating

Different evidence by use (topical vs. injectable, approved vs. off-label).

Important: Star ratings measure evidence strength, not safety.

Peptide Comparison Table

Every compound in this category, ranked by evidence strength.

Peptide	FDA Status	Evidence	Key Note
Cerebrolysin	Approved in Europe/Asia / Research in US	★★★☆☆	RCT data for stroke/dementia; limited for healthy cognition
Cortexin	Approved in Russia / Research in US	★★★☆☆	Russian clinical studies; limited independent replication
Semax	Approved in Russia / Research in US	★★★☆☆	Published human studies; primarily Russian literature
Selank	Approved in Russia / Research in US	★★★☆☆	Published human studies; primarily Russian literature
SS-31 (Elamipretide)	Clinical-Stage Research	★★★☆☆	Phase II human trials; primarily mitochondrial/metabolic focus
Thymosin Alpha-1	Approved in 35+ countries / Research in US	★★★☆☆	Immune evidence strong; cognitive use more limited
Epithalon	Research	★★★☆☆	Russian human data exists; limited Western RCT replication
N-Acetyl Semax	Research	★★☆☆☆	Less studied than Semax; limited human data
Semax Amidate	Research	★★☆☆☆	Limited human data
N-Acetyl Selank	Research	★★☆☆☆	Limited human data
Selank Amidate	Research	★★☆☆☆	Limited human data
Noopept (GVS-111)	Research	★★☆☆☆	Some Russian human studies; limited Western RCT data
Humanin	Research	★★☆☆☆	Primarily preclinical; early human observational
VIP (Vasoactive Intestinal Peptide)	Research	★★☆☆☆	Some human data (CIRS/Shoemaker); cognitive claims early
PACAP	Research	★★☆☆☆	Primarily preclinical
DSIP (Delta Sleep-Inducing Peptide)	Research	★★☆☆☆	Some human studies but inconsistent results
Dihexa	Research	★☆☆☆☆	Primarily animal; no published human trials
P21 (CNTF-derived)	Research	★☆☆☆☆	Very early; no human data
Adamax	Research	★☆☆☆☆	No published human trials
BDNF Peptide Fragments	Research	★☆☆☆☆	Experimental; no human trial data
NGF (Nerve Growth Factor) Fragments	Research	★☆☆☆☆	Experimental; no human trial data
NT-3 Peptide Fragments	Research	★☆☆☆☆	Experimental; no human trial data

Top Compounds

Semax (★★★☆☆), Approved in Russia

A synthetic ACTH fragment studied for neuroprotection and cognitive enhancement. Published human studies exist, primarily in Russian literature. Approved in Russia; research-only in the US.

Selank (★★★☆☆), Approved in Russia

An anxiolytic peptide studied for stress reduction and cognitive function. Published human data on anxiety; cognitive enhancement evidence is more limited. Approved in Russia; research-only in the US.

SS-31 / Elamipretide (★★★☆☆), Clinical-Stage

Phase II human trials completed, primarily for mitochondrial disease. Cognitive applications are investigational. An interesting compound at the intersection of mitochondrial health and neurological function.

Thymosin Alpha-1 (★★★☆☆), Approved in 35+ countries

Primarily an immune modulator, but cognitive applications are emerging. The immune-brain connection is an active research area.

Frequently Asked Questions

What is Semax and does it work?

Semax is a synthetic peptide derived from ACTH, studied for neuroprotection and cognitive enhancement. Russian human studies show positive effects on memory and attention. Evidence rating: ★★★☆☆ (preliminary human evidence, primarily Russian literature). It is approved in Russia but not FDA-approved in the US.

What is the best peptide for brain function?

No peptide is FDA-approved for cognitive enhancement in healthy individuals. Cerebrolysin has the most RCT data but for stroke/dementia, not healthy cognition (★★★☆☆). Semax and Selank have published human studies from Russia (★★★☆☆). All are rated ★★★☆☆ or lower for cognitive enhancement specifically.

Is Dihexa effective for cognition?

Dihexa is a synthetic peptide studied for cognitive enhancement and synaptogenesis. Evidence is primarily animal-based with no published human trials. Evidence rating: ★☆☆☆☆ (mechanistic/preliminary only). It is not approved for human use.

What is Cerebrolysin used for?

Cerebrolysin is approved in several European and Asian countries for stroke recovery and dementia. It has RCT data for these indications. Evidence for healthy cognitive enhancement is more limited. It is not FDA-approved in the US.

Are nootropic peptides safe?

Star ratings measure evidence strength, not safety. Most cognitive enhancement peptides are research compounds or approved only abroad. No peptide is FDA-approved for cognitive enhancement in healthy people. Always consult a qualified healthcare provider before considering any cognitive enhancement compound.

What is the difference between Semax and Selank?

Semax is derived from ACTH and studied primarily for cognitive enhancement and neuroprotection. Selank is an anxiolytic (anti-anxiety) peptide also studied for cognitive function. Both are approved in Russia, both are rated ★★★☆☆, and both are research-only in the US. They are sometimes used together in Russian medical practice.

Get the Complete Guide

Every compound in this category, fully profiled with mechanisms, evidence ratings, FDA status, and research citations.

Get the Cognitive Enhancement Guide, $19.99 →

One-time purchase. Instant download. No subscription.